Mielóma multiplex: vizsgálatok itt: India
5 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- Where
- Ahmedabad, Belagavi, Gurugram, Ludhiana, Madurai, Mumbai, Puducherry, Varanasi
- Életkor
- 18 év and over
- People
- 810 worldwide
- Run by
- Celgene
See details and how to joinNCT05519085 - 2. fázisTaking peopleLess Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Multiple Myeloma
- Where
- Navi Mumbai
- Életkor
- 18 év and over
- People
- 52
- Run by
- Tata Memorial Centre
See details and how to joinNCT07891923 - 3. fázisTaking peopleA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Bengaluru, Gūrgaon, Jaipur, Kolkata, New Delhi, Pune
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07518186 - 3. fázisTaking peopleA Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Ahmedabad, Bangalore, Hyderabad, Kolkata, Pune, Sushrut Hospital and Research
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00 - 1. fázisTaking peopleStudy of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
- Where
- Bangalore, Gandhinagar, Hyderabad, Pune
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Ichnos Sciences SA
See details and how to joinNCT05862012 · EU 2023-507071-21-01